3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Neoplasms
7
Breast Neoplasms
7
Anxiety Disorders
6
Depression
4
Smoking Cessation
2
Lymphoma
2
Colorectal Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Stress, Psychological
1
Stage III Gynecologic Cancer
1
Smoking
1
Skin Neoplasms
1
Psychological Well-Being
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Parasomnias
1
Pain, Postoperative
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Motor Activity
1
Melanoma
1
Medically Unexplained Symptoms
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Inflammation
1
Hematopoietic and Lymphoid System Neoplasm
1
Interventions
Cyclophosphamide
18
fludarabine phosphate
14
Peripheral Blood Stem Cell Transplantation
13
Cyclosporine
12
Whole-Body Irradiation
11
Antilymphocyte Serum
10
fludarabine
9
Exercise
9
Busulfan
9
Mycophenolic Acid
8
Melphalan
8
Dexamethasone
8
Blood Specimen Collection
8
Filgrastim
7
Standard of Care
6
Radiotherapy
6
Behavior Therapy
6
Acupuncture Therapy
6
Therapeutics
5
Specimen Handling
5
Palliative Care
5
Methotrexate
5
Granulocyte Colony-Stimulating Factor
5
Etoposide
5
Educational Status
5
Surveys and Questionnaires
4
Stem Cell Transplantation
4
Psychiatric Rehabilitation
4
Practice Guidelines as Topic
4
Methylprednisolone
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Multiple Myeloma
×
Mindfulness
×
Clear all
NCT06063603
2025-09-18
ASCENT
Mayo Clinic
Phase NA
Completed
51 enrolled
8 charts